Alosetron for irritable bowel syndrome

@article{Barbehenn2000AlosetronFI,
  title={Alosetron for irritable bowel syndrome},
  author={Elizabeth K Barbehenn and Peter Lurie and Sidney M. Wolfe},
  journal={The Lancet},
  year={2000},
  volume={356}
}
4 Citations
Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions
TLDR
This review enlightens the landscape of the discovery and development of imidazoles- and benzimidazole-based drugs with an emphasis on structure activity relationship features (SAR), medicinal chemistry, and their mechanism of action.
The Sociology of Medical Evaluation: Case Studies
TLDR
This study analyzes the controversial evaluation of three drugs: two of them having been evaluated by clinical trial and the third one not, in spite of the willingness of the drug manufacturer to undertake this type of evaluation.
Reviewbias in medical research - a narrative review
Reporting bias represents a major problem in the assessment of health care interventions. Several prominent cases have been described in the literature, for example, in the reporting of trials of
Treatment options in irritable bowel syndrome.
  • M. Farthing
  • Medicine
    Best practice & research. Clinical gastroenterology
  • 2004